SALT LAKE CITY, May 17, 2012 /PRNewswire/ –Lineagen today announced the Company completed the testing portion of a 9,000-person research study designed to confirm novel copy number genetic variants and novel next-generation sequence variants associated with autism spectrum disorder (ASD). These variants were discovered by Hakon Hakonarson, M.D., Ph.D., and his team at The Children’s Hospital of Philadelphia (CHOP)’s Center for Applied Genomics and by Mark F. Leppert, Ph.D., and his team at the University of Utah’s Department of Human Genetics
Lineagen Completes 9000-Person Study Focused on Genetic Variants in Individuals Diagnosed with Autism Spectrum …
Posted 18 May 2012 by adminTagged As: city-, genetic, genetic-testing, genetics-, healthcare, lake, nature, research | Categories: Human Genetics | Comments Off
Sequenom Provides Update on Agreement With Coventry Health Care
Posted 18 May 2012 by adminTagged As: a-broad-range, agreement, cmm, collaborative, coventry-health, information, landscape, network-, parties, risks, san, securities, sequenom-center | Categories: Molecular Medicine | Comments Off
SAN DIEGO, May 17, 2012 /PRNewswire/ — Sequenom Inc., (SQNM) through its wholly owned subsidiary Sequenom Center for Molecular Medicine, LLC, (Sequenom CMM) entered into the recently announced provider network participation agreement with Coventry Health Care National Network, Inc.
Osiris stem-cell therapy wins Canadian approval
Posted 18 May 2012 by adminTagged As: approved-its, first, gvhd, osiris-therapeutics, procedures-as-bone, prochymal, thursday-on-news, treatment, world | Categories: Cell Therapy | Comments Off
BOSTON (MarketWatch) — Shares of Osiris Therapeutics jumped 14% to $5.60 in after-hours trading Thursday on news that Canadian regulators have approved its product Prochymal for the treatment of acute graft-vs-host disease, or GVHD, in children.
Osiris Wins Canadian Approval for First Stem-Cell Therapy
Posted 18 May 2012 by adminTagged As: a-huge-deal, a-stem-cell, columbia, drug, edward-tenthoff, first, piper-jaffray, regenerative, sanofis-genzyme | Categories: Cell Therapy | Comments Off
By Meg Tirrell – 2012-05-17T20:35:40Z Osiris Therapeutics Inc. (OSIR) said it won the worlds first approval for a stem-cell drug, gaining clearance in Canada to sell Prochymal for a disease that can attack patients who received bone-marrow transplants. Prochymal was approved for the treatment of acute graft versus host disease in children for whom steroids havent worked, the Columbia, Maryland-based company said today in a statement.
Gene therapy restores movement in children bedridden with AADC
Posted 18 May 2012 by adminTagged As: a-rare-disease, absolutely, children, college, florida-, national, national-taiwan, opens-the-door, possibility, science, study, the-children, therapy-center-, university | Categories: Gene Therapy | Comments Off
Using gene transfer techniques pioneered by University of Florida faculty, Taiwanese doctors have restored some movement in four children bedridden with a rare, life-threatening neurological disease. The first-in-humans achievement may also be helpful for more common diseases such as Parkinson’s that involve nerve cell damage caused by lack of a crucial molecule in brain tissue
Children with rare, incurable brain disease improve after gene therapy
Posted 18 May 2012 by adminTagged As: a-rare-disease, aadc, children, college, corrective, florida-, genetics-, journal, national-taiwan, regenerative, science, study, taiwan, taiwanese, university | Categories: Gene Therapy | Comments Off
ScienceDaily (May 16, 2012) Using gene transfer techniques pioneered by University of Florida faculty, Taiwanese doctors have restored some movement in four children bedridden with a rare, life-threatening neurological disease. The first-in-humans achievement may also be helpful for more common diseases such as Parkinson’s that involve nerve cell damage caused by lack of a crucial molecule in brain tissue. The results are reported today in the journal Science Translational Medicine.
Gene Therapy for Brain Disease
Posted 18 May 2012 by adminTagged As: a-good-copy, only, patients, science, study, surgery, taiwanese, university | Categories: Gene Therapy | Comments Off
Delivering a missing enzyme to the brains of paralyzed children with a rare, life-threatening neurological disease restores movement and builds muscle mass.
Irving Weissman – Stem Cells and Cancer – Video
Posted 18 May 2012 by adminTagged As: | Categories: Stem Cells | Comments Off
16-05-2012 08:11
Father's organ donor lessons appeal
Posted 18 May 2012 by adminTagged As: a-has-called, a-new-law, and-college, called-for, leukaemia-has, lost-his, new-law, organs-and, Stem Cells, students-lessons | Categories: Stem Cells | Comments Off
A father who lost his son to leukaemia has called for a new law to give school and college students lessons about donating blood, organs and stem cells.
Aastrom Biosciences to Present at World Stem Cells & Regenerative Medicine Congress
Posted 18 May 2012 by adminTagged As: aastrom-biosciences, availability, clinical-trial, congress, development, london, manufacture, park, phase, place-on-monday, securities, through-the-use, treatment, visit-the-trial, website-at-www | Categories: Stem Cells | Comments Off
ANN ARBOR, Mich., May 17, 2012 (GLOBE NEWSWIRE) — Aastrom Biosciences, Inc. (Nasdaq:ASTM – News), the leading developer of patient-specific expanded multicellular therapies for the treatment of severe chronic cardiovascular diseases, today announced that company president and CEO Tim Mayleben will be presenting at the World Stem Cells & Regenerative Medicine Congress at the Park Plaza hotel in London, UK.